- Recent Funding
- Investors
- Alexandria Venture Investments
Alexandria Venture Investments portfolio
Alexandria Venture Investments has 24 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Precede's $83.5M Series B+ round in January 2026, alongside Illumina Ventures, Lilly Asia Ventures, OUP and 6 others. By category, its portfolio leans toward Health and bio (23) and Data and analytics (2). It has co-invested with ARCH Venture Partners, GV and 8VC, most often ARCH Venture Partners (5 rounds).
What Alexandria Venture Investments invests in
- Health and bio · 23 · 96%
- Data and analytics · 2 · 8%
- Education · 2 · 8%
- Consumer and social · 1 · 4%
- Cybersecurity · 1 · 4%
- Manufacturing and industrial · 1 · 4%
- Commerce and retail · 1 · 4%
- Logistics and mobility · 1 · 4%
Alexandria Venture Investments recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $83.5M | Illumina Ventures, Lilly Asia Ventures, OUP +6 | ||
| Series A · $101M | DCVC Bio (lead), Bill & Melinda Gates Foundation, Lux Capital (lead) +1 | ||
| Series B+ · $132M | Qatar Investment Authority, Third Rock Ventures, Omega Funds +3 | ||
| Series B+ · $90M | Qatar Investment Authority, Johnson & Johnson Innovation (lead), Fidelity +6 | ||
| Series A · $67M | Polaris, Nextech Invest, GV (lead) | ||
| Series A · $400M | ARCH Venture Partners (lead), Fidelity Management & Research Company, Farallon Capital Management +5 | ||
| Series A · $100M | EcoR1 Capital (lead), ARCH Venture Partners (lead), Leaps by Bayer (lead) +2 | ||
| Series A · $100M | Access Biotechnology, Vertex Ventures HC, Digitalis Ventures +2 |
How Alexandria Venture Investments invests
Alexandria Venture Investments portfolio companies
PPrecede$83.5MSeries B+ · Jan 2026
NNilo Therapeutics$101MSeries A · Oct 2025
AARTBIO$132MSeries B+ · Jul 2025
BBright Peak Therapeutics$90MSeries B+ · Jun 2024
DDelphia Therapeutics$67MSeries A · May 2024
MMirador Therapeutics$400MSeries A · Mar 2024
PParatus Sciences$100MSeries A · Mar 2023
MMatchpoint Therapeutics$100MSeries A · Oct 2022
CCartography Biosciences$57MSeries A · Jul 2022
IImmunai$215MSeries B+ · Oct 2021
EEncodia$75MSeries B+ · Jan 2021
DDren BioSeries A · Oct 2020MMOMA Therapeutics$86MSeries A · Apr 2020
AAspen Neuroscience$6.5MSeed · Dec 2019
LLifeMine Therapeutics$55MSeries A · Sep 2017
KKhartis Therapeuticsbacker
OOverT Biobacker
IInspirnabacker
JJupiter Bioventuresbacker
XXilisbacker
AAdaptive Phage Therapeuticsbacker
SSoli Organicbacker
SSeawolf Therapeuticsbacker
AAffini-Tbacker
| Company | Round with Alexandria Venture Investments | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $83.5M | $83.5M | Jan 12, 2026 Series B+ |
Health and bio |
Series A · $101M | $101M | Oct 8, 2025 Series A |
Health and bio |
Series B+ · $132M | $245M | Jul 29, 2025 Series B+ |
Health and bio |
Series B+ · $90M | $125M | Aug 17, 2026 Series B+ |
Health and bio |
Series A · $67M | $67M | May 2, 2024 Series A |
Health and bio |
Series A · $400M | $650M | Jan 13, 2026 Series B+ |
Health and bio |
Series A · $100M | $100M | Mar 8, 2023 Series A |
Health and bio |
Series A · $100M | $250M | Oct 7, 2026 Series B+ |
Health and bio |
Series A · $57M | $124M | Oct 2, 2025 Series B+ |
Health and bio |
Series B+ · $215M | $295M | Oct 28, 2021 Series B+ |
Health and bio |
Series B+ · $75M | $75M | Jun 26, 2024 Series A |
Health and bio |
Series A | $415M | Oct 29, 2026 round |
Health and bio |
Series A · $86M | $236M | May 10, 2022 Series B+ |
Health and bio |
Seed · $6.5M | $339M | Nov 20, 2025 Series B+ |
Health and bio |
Series A · $55M | $543M | Aug 6, 2026 Series B+ |
Health and bio |
backer | $95M | Aug 13, 2026 Series B+ |
Health and bio |
backer | $16M | May 6, 2024 Seed |
Health and bio |
backer | $50M | Jul 11, 2022 Series B+ |
Health and bio |
backer | undisclosed | Oct 8, 2025 Series B+ |
Health and bio |
backer | $92M | Sep 16, 2022 Series A |
Health and bio |
backer | $85M | Jun 13, 2023 Series B+ |
Commerce and retail |
backer | $125M | Oct 12, 2022 round |
Health and bio |
backer | $100M | Nov 16, 2026 Seed |
Health and bio |
backer | $175M | Mar 22, 2022 Series A |
Most frequent co-investors
AARCH Venture Partners5 shared rounds · last Mar 21, 2024
GGV3 shared rounds · last May 2, 2024
88VC3 shared rounds · last Jul 20, 2022
QQatar Investment Authority2 shared rounds · last Jul 29, 2025
TThird Rock Ventures2 shared rounds · last Jul 29, 2025
PPolaris2 shared rounds · last May 2, 2024
NNextech Invest2 shared rounds · last May 2, 2024
OOrbiMed2 shared rounds · last Mar 21, 2024
SSanofi Ventures2 shared rounds · last Mar 21, 2024
BBristol-Myers Squibb1 shared round · last Jan 12, 2026
OOUP1 shared round · last Jan 12, 2026
LLilly Asia Ventures1 shared round · last Jan 12, 2026
Similar investors
HHV Capital24 companies · 5 deals in 12 mo
IInvus25 companies · 9 deals in 12 mo
JJanus Henderson Investors23 companies · 11 deals in 12 mo
EEmerson Collective23 companies · 6 deals in 12 mo
EEuropean Investment Bank Group23 companies · 5 deals in 12 mo
EEarlybird VC23 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 15 rounds on Recent Funding that name Alexandria Venture Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Alexandria Venture Investments, which is a subset of its real portfolio. API: /api/v1/investors/alexandria-venture-investments (get a free API key). More: the most active VC firms and new venture capital funds.